On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.

Popular GLP-1 medications ... with diabetes who continued to take the medications they had already been prescribed without any changes to their therapy, meaning they didn’t start a new drug ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

Insulin, sulfonylureas, and TZDs are diabetes medications that may cause weight gain. But some, like metformin, may have weight loss potential. Others may be neutral to any weight changes.

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...